Brinzolamide
Indications
Registered South African indications:
- Open angle glaucoma
- Ocular hypertension
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to sulphonamides
- Severe renal impairment
- Hyperchloraemic acidosis
Cautions
- Pregnancy
- Breastfeeding
- Hepatic impairment
- Pseudoexfoliative glaucoma
- Pigmentary glaucoma
- Closed angle glaucoma
- Dry eye
- Conditions where the cornea is compromised
- Infants
- Children
- Concomitant use of contact lenses
- May impair ability to drive or operate heavy machinery
Adult dosage
Forms avail. in SA and covered in this monograph: opd
Ocular hypertension
Open angle glaucoma
- Ophthalmic (opd): 1 drop, into affected eye(s), 8-12hrly
If more than one ocular preparation is used, they should be used at least 10mins apart
When substituting for another antiglaucoma medication, discontinue the agent after a one day of full dosing and start brinzolamide the next day
Paediatric dosage
Not established for use in children
Special populations
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Central Nervous System Disorders
- Apathy
- Depression
- Decreased libido
- Nightmare
- Nervousness
- Insomnia
- Motor dysfunction
- Amnesia
- Dizziness
- Paraesthesia
- Headache
- Memory impairment
- Somnolence
- Tremor
- Hypoaesthesia
- Ageusia
Cardiovascular Disorders
- Cardiorespiratory distress
- Bradycardia
- Palpitations
- Angina pectoris
- Arrhythmia
- Tachycardia
- Hypertension
- Hypotension
Respiratory Disorders
- Dyspnoea
- Epistaxis
- Oropharyngeal pain
- Pharyngolaryngeal pain
- Throat irritation
- Upper airway cough syndrome
- Rhinorrhoea
- Sneezing
- Bronchial hyperreactivity
- Upper respiratory tract congestion
- Sinus congestion
- Nasal congestion
- Cough
- Nasal dryness
- Asthma
Gastrointestinal Disorders
- Dysgeusia
- Oesophagitis
- Diarrhoea
- Nausea and vomiting
- Dyspepsia
- Upper abdominal pain
- Abdominal discomfort
- Stomach discomfort
- Flatulence
- Frequent bowel movements
- Gastrointestinal disorder
- Oral hypoaesthesia
- Oral paraesthesia
- Dry mouth
Hepatobiliary Disorders
- Abnormal liver function test
Genitourinary Disorders
- Renal pain
- Pollakiuria
- Erectile dysfunction
Endocrine and Metabolic Disorders
- Decreased appetite
Musculoskeletal Disorders
- Back pain
- Muscle spasms
- Myalgia
- Arthralgia
- Pain in extremity
Skin and Subcutaneous Tissue Disorders
- Maculopapular rash
- Skin tightness
- Urticaria
- Alopecia
- Pruritus
- Dermatitis
- Erythema
Immune, Blood and Lymphatic System Disorders
- Nasopharyngitis
- Pharyngitis
- Sinusitis
- Rhinitis
- Decreased red blood cell count
- Increased blood chloride
- Hypersensitivity
Sensory Disorders
- Blurred vision
- Eye pain
- Foreign body sensation in eyes
- Ocular hyperaemia
- Corneal erosion
- Keratitis
- Punctate keratitis
- Keratopathy
- Deposits in eye
- Corneal staining
- Corneal epithelium disorder
- Blepharitis
- Eye pruritus
- Conjunctivitis
- Eye swelling
- Meibomianitis
- Photophobia
- Dry eye
- Allergic conjunctivitis
- Pterygium
- Scleral pigmentation
- Asthenopia
- Keratoconjunctivitis sicca
- Subconjunctival cyst
- Conjunctival hyperaemia
- Eyelids pruritus
- Eye discharge
- Eyelid margin crusting
- Corneal oedema
- Diplopia
- Photopsia
- Hypoaesthesia eye
- Periorbital oedema
- Increased optic nerve cup/disc ratio
- Corneal disorder
- Visual disturbance
- Madarosis
- Erythema of eyelid
- Tinnitus
- Vertigo
Interactions
- Oral carbonic anhydrase inhibitors
- CYP3A4 inhibitors
Monitoring
None routine
Mechanism of action
Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. The result is a reduction in intraocular pressure.
Dosage forms
- Eye drops
Formulation
Eye drops (per ml) 10mg
- Azoptic (Novartis South Africa) originator
COMBINATION PREPARATIONS
Brinzolamide/ Timolol
Eye drops (per ml) 10mg/5mg
- Azarga (Novartis South Africa) originator
References
1. SAMF_12th edition_Page 578 2. https://www.medicines.org.uk/emc/medicine/2808 (03/09/2014_Alcon_Azopt_eye drop) 3. https://drive.google.com/drive/folders/0B27NqM_vidrmY3JkU0VzdzlSTU0 (19/07/2001_Alcon_Azoptic_eye drop_Intekom) 4. https://drive.google.com/drive/folders/0B27NqM_vidrmY3JkU0VzdzlSTU0 (30/09/2011_Alcon_Azoptic_eye drop)
Brands & products
3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days olddropsGeneric· 3 products
from R67.18/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Azoptic 5ml eye suspension | 10 mg/ml | 5 | S3 | R335.88 | R67.18 | R117.61 | 701523001 |
| Azarga 5ml | 5 mg/ml | 5 | S4 | R339.09 | R67.82 | R118.49 | 717260001 |
| Simbrinza | 2 mg/ml | 5 | S3 | R345.58 | R69.12 | R120.28 | 3004660001 |
- Azoptic
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.